Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 382 (LINC00382) is a long non-coding RNA (lncRNA) gene located on chromosome 13, annotated in multiple human genome resources[3][11][13]. It belongs to the family of long intergenic non-protein coding RNAs (lincRNAs), which are a subclass of lncRNAs characterized by their position between protein-coding genes and lack of coding potential[7][13]. The primary reported aliases are LINC00382 and TCONS_00021500[9][11]. Unlike protein-coding gene targets, LINC00382 does not have a known therapeutic target role, nor is it a canonical receptor, enzyme, transporter, or disease biomarker. There is currently no established role for LINC00382 in human disease, therapeutic interaction, or as a clinically actionable biomarker[7][9][13]. As with other lincRNAs, its putative biological function is likely regulatory but has not been well characterized for this specific gene[15].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 382 (LINC00382).